An unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions

Journal of Immunology

Volumn 177, Issue 7, 2006, Pages 4907-4916

  Xiong, Zeyu ^a   Liu, Enli ^e   Yan, Yan ^a   Silver, Richard T ^c   Yang, Fan ^a   Chen, Irene H ^a   Chen, Yangyang ^a   Verstovsek, Srdan ^d   Wang, Hong ^a   Prchal, Josef ^b,e   Yang, Xiao Feng ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIGEN MPD6; IMMUNOGLOBULIN G ANTIBODY; MESSENGER RNA; RECOMBINANT SOMATOMEDIN C; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DNA LIBRARY; GENE EXPRESSION; GENE LOCATION; GENE STRUCTURE; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOSTIMULATION; INTERNAL RIBOSOME ENTRY SITE; MYELOPROLIFERATIVE DISORDER; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYCYTHEMIA; PRIORITY JOURNAL; PROSTATE CANCER; REPORTER GENE; RNA TRANSLATION; TESTIS; TUMOR CELL; UPREGULATION;

EID: 33749157848     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.7.4907     Document Type: Article

References (85)

1. Belardelli, F., M. Ferrantini, E. Proietti, and J. M. Kirkwood. 2002. Interferon-α in tumor immunity and immunotherapy. Cytokine Growth Factor Rev. 13: 119-134.
2. Liu, E., J. Jelinek, Y. D. Pastore, Y. Guan, J. F. Prchal, and J. T. Prchal. 2003. Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin. Blood 101: 3294-3301.
3. Lengfelder, E., U. Berger, and R. Hehlmann. 2000. Interferon-α in the treatment of polycythemia vera. Ann. Hematol. 79: 103-109.
4. Fujii, S. 2000. Role of interferon-α and clonally expanded T cells in the immunotherapy of chronic myelogenous leukemia. Leuk. Lymphoma 38: 21-38.
5. Sacchi, S., H. Kantarjian, S. O'Brien, P. R. Cohen, S. Pierce, and M. Talpaz. 1995. Immune-mediated and unusual complications during interferon-alfa therapy in chronic myelogenous leukemia. J. Clin. Oncol. 13: 2401-2407.
6. Wu, C. J., X. F. Yang, S. McLaughlin, D. Neuberg, C. Canning, B. Stein, E. P. Alyea, R. J. Soiffer, G. Dranoff, and J. Ritz. 2000. Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia. J. Clin. Invest. 106: 705-714.
7. Yang, X. F., C. J. Wu, S. McLaughlin, A. Chillemi, K. S. Wang, C. Canning, E. P. Alyea, P. Kantoff, R. J. Soiffer, G. Dranoff, and J. Ritz. 2001. CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia. Proc. Natl. Acad. Sci. USA 98: 7492-7497.
8. Yang, X. F., C. J. Wu, L. Chen, E. P. Alyea, C. Canning, P. Kantoff, R. J. Soiffer, G. Dranoff, and J. Ritz. 2002. CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells. Cancer Res. 62: 5517-5522.
9. Sahin, U., O. Tureci, H. Schmitt, B. Cochlovius, T. Johannes, R. Schmits, F. Stenner, G. Luo, I. Schobert, and M. Pfreundschuh. 1995. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA 92: 11810-11813.
10. Wu, C. J., M. Biernacki, J. L. Kutok, S. Rogers, L. Chen, X. F. Yang, R. J. Soiffer, and J. Ritz. 2005. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells. Clin. Cancer Res. 11: 4504-4511.
11. Yang, X.-F., Y. Yan, L. Phan, Z. Xiong, J. Jelinek, and J. Prchal. 2002. Upregulation of cancer-testis antigens in polycythemia vera cells suggests their potential role in immune responses against myeloproliferation. Blood 100: 348b.
12. Jager, E., Y. Nagata, S. Gnjatic, H. Wada, E. Stockert, J. Karbach, P. R. Dunbar, S. Y. Lee, A. Jungbluth, D. Jager, et al. 2000. Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc. Natl. Acad. Sci. USA 97: 4760-4765.
13. Yang, F., and X. F. Yang. 2005. New concepts in tumor antigens: their significance in future immunotherapies for tumors. Cell. Mol. Immunol. 2: 331-341.
14. Guilloux, Y., S. Lucas, V. G. Brichard, A. Van Pel, C. Viret, E. De Plaen, F. Brasseur, B. Lethe, F. Jotereau, and T. Boon. 1996. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. J. Exp. Med. 183: 1173-1183.
15. Wang, R. F., M. R. Parkhurst, Y. Kawakami, P. F. Robbins, and S. A. Rosenberg. 1996. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J. Exp. Med. 183: 1131-1140.
16. Schwab, S. R., J. A. Shugart, T. Horng, S. Malarkannan, and N. Shastri. 2004. Unanticipated antigens: translation initiation at CUG with leucine. PLoS Biol. 2: e366.
17. Malarkannan, S., T. Horng, P. P. Shih, S. Schwab, and N. Shastri. 1999. Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. Immunity 10: 681-690.
18. Shastri, N., S. Schwab, and T. Serwold. 2002. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu. Rev. Immunol. 20: 463-493.
19. Yan, Y., L. Phan, F. Yang, M. Talpaz, Y. Yang, Z. Xiong, B. Ng, N. A. Timchenko, C. J. Wu, J. Ritz, et al. 2004. A novel mechanism of alternative promoter and splicing regulates the epitope generation of tumor antigen CML66-L. J. Immunol. 172: 651-660.
20. Ng, B., F. Yang, D. P. Huston, Y. Yan, Y. Yang, Z. Xiong, L. E. Peterson, H. Wang, and X.-F. Yang. 2004. Increased non-canonical splicing of autoantigen transcripts provides the structural basis for expression of untolerized epitopes. J. Allergy Clin. Immunol. 114: 1463-1470.
21. Yang, F., I. H. Chen, Z. Xiong, Y. Yan, H. Wang and X.-F. Yang. Model of stimulation-responsive splicing and strategies in identification of immunogenic isoforms of tumor antigens and autoantigens. Clin. Immunol. In press.
22. Hellen, C. U., and P. Sarnow. 2001. Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev. 15: 1593-1612.
23. Stoneley, M., and A. E. Willis. 2004. Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression. Oncogene 23: 3200-3207.
24. Gure, A. O., O. Tureci, U. Sahin, S. Tsang, M. J. Scanlan, E. Jager, A. Knuth, M. Pfreundschuh, L. J. Old, and Y. T. Chen. 1997. SSX: a multigene family with several members transcribed in normal testis and human cancer. Int. J. Cancer 72: 965-971.
25. Mignone, F., G. Grillo, F. Licciulli, M. Iacono, S. Liuni, P. J. Kersey, J. Duarte, C. Saccone, and G. Pesole. 2005. UTRdb and UTRsite: a collection of sequences and regulatory motifs of the untranslated regions of eukaryotic mRNAs. Nucleic Acids Res. 33: D141-D146.
26. Zuker, M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31: 3406-3415.
27. Hofacker, I. L. 2003. Vienna RNA secondary structure server. Nucleic Acids Res. 31: 3429-3431.
28. Hawley, T. S., W. G. Telford, A. Ramezani, and R. G. Hawley. 2001. Four-color flow cytometric detection of retrovirally expressed red, yellow, green, and cyan fluorescent proteins. BioTechniques 30: 1028-1034.
29. Smith, J. K., A. A. Siddiqui, G. A. Krishnaswamy, R. Dykes, S. L. Berk, M. Magee, W. Joyner, and J. Cummins. 1999. Oral use of interferon-α stimulates ISG-15 transcription and production by human buccal epithelial cells. J. Interferon Cytokine Res. 19: 923-928.
30. Yang, X. F., G. F. Weber, and H. Cantor. 1997. A novel Bcl-x isoform connected to the T cell receptor regulates apoptosis in T cells. Immunity 7: 629-639.
31. Streilein, J. W. 1995. Unraveling immune privilege. Science 270: 1158-1159.
32. Chen, Y. T. 2000. Cancer vaccine: identification of human tumor antigens by SEREX. Cancer J. Sci. Am. 6(Suppl. 3): S208-S217.
33. Hoeppner, L. H., J. A. Dubovsky, E. J. Dunphy, and D. G. McNeel. 2006. Humoral immune responses to testis antigens in sera from patients with prostate cancer. Cancer Immun. 6: 1.
34. Okada, T., M. Akada, T. Fujita, T. Iwata, Y. Goto, K. Kido, T. Okada, Y. Matsuzaki, K. Kobayashi, S. Matsuno, et al. 2006. A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers. Clin. Cancer Res. 12: 191-197.
35. Sivasubramanian, N., G. Adhikary, P. C. Sil, and S. Sen. 1996. Cardiac myotrophin exhibits rel/NF-κB interacting activity in vitro. J. Biol. Chem. 271: 2812-2816.
36. Gupta, S., and S. Sen. 2002. Myotrophin-κB DNA interaction in the initiation process of cardiac hypertrophy. Biochim. Biophys. Acta 1589: 247-260.
37. Knuefermann, P., P. Chen, A. Misra, S. P. Shi, M. Abdellatif, and N. Sivasubramanian. 2002. Myotrophin/V-1, a protein up-regulated in the failing human heart and in postnatal cerebellum, converts NFκB p50-p65 heterodimers to p50-p50 and p65-p65 homodimers. J. Biol. Chem. 277: 23888-23897.
38. Bullock, T. N., A. E. Patterson, L. L. Franlin, E. Notidis, and L. C. Eisenlohr. 1997. Initiation codon scanthrough versus termination codon readthrough demonstrates strong potential for major histocompatibility complex class I-restricted cryptic epitope expression. J. Exp. Med. 186: 1051-1058.
39. Liu, H. X., L. Cartegni, M. Q. Zhang, and A. R. Krainer. 2001. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat. Genet. 27: 55-58.
40. Kozak, M. 1996. Interpreting cDNA sequences: some insights from studies on translation. Mamm. Genome 7: 563-574.
41. Shastri, N., V. Nguyen, and F. Gonzalez. 1995. Major histocompatibility class I molecules can present cryptic translation products to T-cells. J. Biol. Chem. 270: 1088-1091.
42. Aubsubel, F., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1999. Screening of recombinant DNA libraries. In Current Protocols in Molecular Biology. V. Chanda, ed. Wiley, New York. p. A.1C.3.
43. Landschulz, W. H., P. F. Johnson, and S. L. McKnight. 1988. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240: 1759-1764.
44. Furuno, M., T. Kasukawa, R. Saito, J. Adachi, H. Suzuki, R. Baldarelli, Y. Hayashizaki, and Y. Okazaki. 2003. CDS annotation in full-length cDNA sequence. Genome Res. 13: 1478-1487.
45. Jameson, B. A., and H. Wolf. 1988. The antigenic index: a novel algorithm for predicting antigenic determinants. Comput. Appl. Biosci. 4: 181-186.
46. Mahler, M., M. Bluthner, and K. M. Pollard. 2003. Advances in B-cell epitope analysis of autoantigens in connective tissue diseases. Clin. Immunol. 107: 65-79.
47. Preuss, K. D., C. Zwick, C. Bormann, F. Neumann, and M. Pfreundschuh. 2002. Analysis of the B-cell repertoire against antigens expressed by human neoplasms. Immunol. Rev. 188: 43-50.
48. Komar, A. A., and M. Hatzoglou. 2005. Internal ribosome entry sites in cellular mRNAs: mystery of their existence. J. Biol. Chem. 280: 23425-23428.
49. Holcik, M., C. Lefebvre, C. Yeh, T. Chow, and R. G. Korneluk. 1999. A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection. Nat. Cell Biol. 1: 190-192.
50. Hennecke, M., M. Kwissa, K. Metzger, A. Oumard, A. Kroger, R. Schirmbeck, J. Reimann, and H. Hauser. 2001. Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs. Nucleic Acids Res. 29: 3327-3334.
51. Kraunus, J., D. H. Schaumann, J. Meyer, U. Modlich, B. Fehse, G. Brandenburg, D. von Laer, H. Klump, A. Schambach, J. Bohne, and C. Baum. 2004. Self-inactivating retroviral vectors with improved RNA processing. Gene Ther. 11: 1568-1578.
52. Kralovics, R., D. W. Stockton, and J. T. Prchal. 2003. Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease. Blood 102: 3793-3796.
53. Bhattachary-Chatterjee, M., R. Nath Baral, S. K. Chatterjee, R. Das, H. Zeytin, M. Chakraborty, and K. A. Foon. 2000. Counterpoint: cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine. Cancer Immunol. Immunother. 49: 133-141.
54. Levine, R. L., M. Wadleigh, J. Cools, B. L. Ebert, G. Wernig, B. J. Huntly, T. J. Boggon, I. Wlodarska, J. J. Clark, S. Moore, et al. 2005. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7: 387-397.
55. Kralovics, R., F. Passamonti, A. S. Buser, S. S. Teo, R. Tiedt, J. R. Passweg, A. Tichelli, M. Cazzola, and R. C. Skoda. 2005. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N. Engl. J. Med. 352: 1779-1790.
56. Zhao, R., S. Xing, Z. Li, X. Fu, Q. Li, S. B. Krantz, and Z. J. Zhao. 2005. Identification of an acquired JAK2 mutation in polycythemia vera. J. Biol. Chem. 280: 22788-22792.
57. James, C., V. Ugo, J. P. Le Couedic, J. Staerk, F. Delhommeau, C. Lacout, L. Garcon, H. Raslova, R. Berger, A. Bennaceur-Griscelli, et al. 2005. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434: 1144-1148.
58. Baxter, E. J., L. M. Scott, P. J. Campbell, C. East, N. Fourouclas, S. Swanton, G. S. Vassiliou, A. J. Bench, E. M. Boyd, N. Curtin, et al. 2005. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365: 1054-1061.
59. Verma, A., S. Kambhampati, S. Parmar, and L. C. Platanias. 2003. Jak family of kinases in cancer. Cancer Metastasis Rev. 22: 423-434.
60. Jager, D., C. Taverna, A. Zippelius, and A. Knuth. 2004. Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning. Cancer Immunol. Immunother. 53: 144-147.
61. Ehlken, H., D. Schadendorf, and S. Eichmuller. 2004. Humoral immune response against melanoma antigens induced by vaccination with cytokine gene-modified autologous tumor cells. Int. J. Cancer 108: 307-313.
62. Okada, H., J. Attanucci, K. M. Giezeman-Smits, C. Brissette-Storkus, W. K. Fellows, A. Gambotto, L. F. Pollack, K. Pogue-Geile, M. T. Lotze, M. E. Bozik, and W. H. Chambers. 2001. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo. Cancer Res. 61: 2625-2631.
63. Ono, T., S. Sato, N. Kimura, M. Tanaka, A. Shibuya, L. J. Old, and E. Nakayama. 2000. Serological analysis of BALB/c methylcholanthrene sarcoma meth A by SEREX: identification of a cancer/testis antigen. Int. J. Cancer 88: 845-851.
64. Schwab, S. R., K. C. Li, C. Kang, and N. Shastri. 2003. Constitutive display of cryptic translation products by MHC class 1 molecules. Science 301: 1367-1371.
65. Molldrem, J. J., P. P. Lee, C. Wang, K. Felio, H. M. Kantarjian, R. E. Champlin, and M. M. Davis. 2000. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat. Med. 6: 1018-1023.
66. Gilbert, H. S. 2001. Current management in polycythemia vera. Semin. Hematol. 38: 25-28.
67. Certa, U., M. Wilhelm-Seiler, S. Foser, C. Broger, and M. Neeb. 2003. Expression modes of interferon-α inducible genes in sensitive and resistant human melanoma cells stimulated with regular and pegylated interferon-α. Gene 315: 79-86.
68. Baechler, E. C., F. M. Batliwalla, G. Karypis, P. M. Gaffney, W. A. Ortmann, K. J. Espe, K. B. Shark, W. J. Grande, K. M. Hughes, V. Kapur, et al. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 100: 2610-2615.
69. Ng, B., F. Yang, D. P. Huston, Y. Yan, Y. Yang, Z. Xiong, L. E. Peterson, H. Wang, and X. F. Yang. 2004. Increased noncanonical splicing of autoantigen transcripts provides the structural basis for expression of untolerized epitopes. J. Allergy Clin. Immunol. 114: 1463-1470.
70. Ludewig, B., T. Junt, H. Hengartner, and R. M. Zinkernagel. 2001. Dendritic cells in autoimmune diseases. Curr. Opin. Immunol. 13: 657-662.
71. Zinkernagel, R. M., and H. Hengartner. 2001. Regulation of the immune response by antigen. Science 293: 251-253.
72. Bauer, C., I. Diesinger, N. Brass, H. Steinhart, H. Iro, and E. U. Meese. 2001. Translation initiation factor eIF-4G is immunogenic, overexpressed, and amplified in patients with squamous cell lung carcinoma. Cancer 92: 822-829.
73. Nagata, Y., S. Ono, M. Matsuo, S. Gnjatic, D. Valmori, G. Ritter, W. Garrett, L. J. Old, and I. Mellman. 2002. Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations. Proc. Natl. Acad. Sci. USA 99: 10629-10634.
74. Steinman, R. M., K. Inaba, S. Turley, P. Pierre, and I. Mellman. 1999. Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum. Immunol. 60: 562-567.
75. Davidoff, A. M., J. D. Iglehart, and J. R. Marks. 1992. Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc. Natl. Acad. Sci. USA 89: 3439-3442.
76. Thery, C., M. Boussac, P. Veron, P. Ricciardi-Castagnoli, G. Raposo, J. Garin, and S. Amigorena. 2001. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166: 7309-7318.
77. Moudgil, K., and Sercarz, E. E. 1998. Antigenic determinants involved in induction and propagation of autoimmunity. In The Autoimmune Diseases, 3rd Ed. N. Rose, and I. R. Mackay, eds. Academic, San Diego, pp. 45-58.
78. Simpson, E., D. Scott, and P. Chandler. 1997. The male-specific histocompatibility antigen, H-Y: a history of transplantation, immune response genes, sex determination and expression cloning. Annu. Rev. Immunol. 15: 39-61.
79. Talpaz, M., F. Ravandi, R. Kurzrock, Z. Estrov, and H. M. Kantarjian. 2000. Interferon-α and β: Clinical Application. Lippincott Williams & Wilkins, Philadelphia.
80. Bonnal, S., C. Boutonnet, L. Prado-Lourenco, and S. Vagner. 2003. IRESdb: the Internal Ribosome Entry Site database. Nucleic Acids Res. 31: 427-428.
81. Stoneley, M., S. A. Chappell, C. L. Jopling, M. Dickens, M. MacFarlane, and A. E. Willis. 2000. c-Myc protein synthesis is initiated from the internal ribosome entry segment during apoptosis. Mol. Cell. Biol. 20: 1162-1169.
82. Kobayashi, N., K. Saeki, and A. Yuo. 2003. Granulocyte-macrophage colony-stimulating factor and interleukin-3 induce cell cycle progression through the synthesis of c-Myc protein by internal ribosome entry site-mediated translation via phosphatidylinositol 3-kinase pathway in human factor-dependent leukemic cells. Blood 102: 3186-3195.
83. Holcik, M., N. Sonenberg, and R. G. Korneluk. 2000. Internal ribosome initiation of translation and the control of cell death. Trends Genet. 16: 469-473.
84. Rivas-Estilla, A. M., Y. Svitkin, M. Lopez Lastra, M. Hatzoglou, A. Sherker, and A. E. Koromilas. 2002. PKR-dependent mechanisms of gene expression from a subgenomic hepatitis C virus clone. J. Virol. 76: 10637-10653.
85. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67: 227-264.